Results

Johnson & Johnson

10/15/2021 | Press release | Distributed by Public on 10/15/2021 08:13

OPSYNVI® (macitentan and tadalafil) Becomes the First and Only Health CanadaApproved Once Daily Fixed Dose Combination Treatment for Patients with Pulmonary Arterial[...]